Atrial fibrillation causes: Difference between revisions
(78 intermediate revisions by 16 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{| class="infobox" style="float:right;" | |||
|- | |||
| [[File:Siren.gif|30px|link=Atrial fibrillation resident survival guide]]|| <br> || <br> | |||
| [[Atrial fibrillation resident survival guide|'''Resident'''<br>'''Survival'''<br>'''Guide''']] | |||
|} | |||
{| class="infobox" style="float:right;" | |||
|- | |||
| [[File:Critical_pathways_.gif|88px|link=Atrial fibrillation critical pathways]]|| <br> || <br> | |||
|} | |||
{{Atrial fibrillation}} | {{Atrial fibrillation}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{Hilda}} {{Ochuko}} | ||
==Overview== | ==Overview== | ||
The most common cause of atrial fibrillation is atrial dilation associated with [[hypertension]]. | The most common cause of atrial fibrillation is [[atrium|atrial]] dilation associated with [[hypertension]]. [[Atrial fibrillation]] can be caused by several organic [[heart|cardiac]] [[diseases]], but it has also been reported to have a [[familial]] [[etiology]] in some [[patients]]. Approximately 1/3 of [[patients]] have [[familial atrial fibrillation]] which is due to an underlying [[genetic disorder]]. In developed countries, [[hypertensive heart disease]] and [[coronary heart disease]] are the two most common causes of [[atrial fibrillation]]. However, [[rheumatic heart disease]] is associated with a higher incidence of [[atrial fibrillation]] in developing countries. Life threatening conditions such as [[acute coronary syndromes]], [[electrolyte imbalance]], [[dehydration]], [[hypoxia]], [[pulmonary embolism]], [[myocarditis]] and [[pericarditis]] should be identified and promptly treated. Other general causes such as the advancing [[Ageing|age]] of the population, the [[Hemodynamics|hemodynamic stress]] of [[heart failure]] and [[valvular heart disease]], [[myocardial ischemia]], a variety of [[inflammation|inflammatory disorders]], [[lung|pulmonary]] [[diseases]], [[alcohol]], [[drug abuse]], and [[endocrine]] disorders. | ||
==Causes== | ==Causes== | ||
===Life Threatening Causes=== | |||
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. The following are some of the well known life threatening causes of [[atrial fibrillation]]:<ref name="Fox-2004">{{Cite journal | last1 = Fox | first1 = CS. | last2 = Parise | first2 = H. | last3 = D'Agostino | first3 = RB. | last4 = Lloyd-Jones | first4 = DM. | last5 = Vasan | first5 = RS. | last6 = Wang | first6 = TJ. | last7 = Levy | first7 = D. | last8 = Wolf | first8 = PA. | last9 = Benjamin | first9 = EJ. | title = Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. | journal = JAMA | volume = 291 | issue = 23 | pages = 2851-5 | month = Jun | year = 2004 | doi = 10.1001/jama.291.23.2851 | PMID = 15199036 }}</ref><ref name="Zimetbaum-2000">{{Cite journal | last1 = Zimetbaum | first1 = PJ. | last2 = Josephson | first2 = ME. | last3 = McDonald | first3 = MJ. | last4 = McClennen | first4 = S. | last5 = Korley | first5 = V. | last6 = Ho | first6 = KK. | last7 = Papageorgiou | first7 = P. | last8 = Cohen | first8 = DJ. | title = Incidence and predictors of myocardial infarction among patients with atrial fibrillation. | journal = J Am Coll Cardiol | volume = 36 | issue = 4 | pages = 1223-7 | month = Oct | year = 2000 | doi = | PMID = 11028474 }}</ref><ref name="Goldhaber-1999">{{Cite journal | last1 = Goldhaber | first1 = SZ. | last2 = Visani | first2 = L. | last3 = De Rosa | first3 = M. | title = Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) | journal = Lancet | volume = 353 | issue = 9162 | pages = 1386-9 | month = Apr | year = 1999 | doi = | PMID = 10227218 }}</ref> | |||
*[[Congestive heart failure]] | |||
*[[Dehydration]] | |||
*[[Electrolyte disturbance]] | |||
*[[Hypothermia]] | |||
*[[Hypoxia]] | |||
*[[Myocardial infarction]] | |||
*[[Myocarditis]] | |||
*[[Pericarditis]] | |||
*[[Pulmonary embolism]] | |||
*[[Uremic pericarditis]] | |||
===Common Causes=== | ===Common Causes=== | ||
The following are the common causes of [[atrial fibrillation]]:<ref name="Krahn-1995">{{Cite journal | last1 = Krahn | first1 = AD. | last2 = Manfreda | first2 = J. | last3 = Tate | first3 = RB. | last4 = Mathewson | first4 = FA. | last5 = Cuddy | first5 = TE. | title = The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. | journal = Am J Med | volume = 98 | issue = 5 | pages = 476-84 | month = May | year = 1995 | doi = 10.1016/S0002-9343(99)80348-9 | PMID = 7733127 }}</ref><ref name="Kannel-1982">{{Cite journal | last1 = Kannel | first1 = WB. | last2 = Abbott | first2 = RD. | last3 = Savage | first3 = DD. | last4 = McNamara | first4 = PM. | title = Epidemiologic features of chronic atrial fibrillation: the Framingham study. | journal = N Engl J Med | volume = 306 | issue = 17 | pages = 1018-22 | month = Apr | year = 1982 | doi = 10.1056/NEJM198204293061703 | PMID = 7062992 }}</ref><ref name="Grigioni-2002">{{Cite journal | last1 = Grigioni | first1 = F. | last2 = Avierinos | first2 = JF. | last3 = Ling | first3 = LH. | last4 = Scott | first4 = CG. | last5 = Bailey | first5 = KR. | last6 = Tajik | first6 = AJ. | last7 = Frye | first7 = RL. | last8 = Enriquez-Sarano | first8 = M. | title = Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome. | journal = J Am Coll Cardiol | volume = 40 | issue = 1 | pages = 84-92 | month = Jul | year = 2002 | doi = | PMID = 12103260 }}</ref> | |||
* [[ | *[[Coronary artery disease]] | ||
* [[ | *[[Hypertensive heart disease]] | ||
*[[Rheumatic heart disease]] | |||
* [[ | |||
===Causes by Organ System=== | ===Causes by Organ System=== | ||
{|style="width:80%; height:100px" border="1" | |||
{|style="width: | |||
|style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" | '''Cardiovascular''' | |style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" | '''Cardiovascular''' | ||
|style="height:100px"; style="width:75%" border="1" bgcolor="Beige" | | |style="height:100px"; style="width:75%" border="1" bgcolor="Beige" | [[Alcoholic cardiomyopathy]], [[atrial infarction|Atrial ischemia]], [[atrial myxoma]], [[atrial septal defect]], [[cardiac surgery]], [[cardiac tumors]], [[cardiomyopathy]], [[conduction disorders]], [[congenital heart disease]], [[congestive heart failure]], [[constrictive pericarditis]], [[coronary artery bypass graft surgery]], [[coronary artery disease]], [[dilated cardiomyopathy]], [[endocarditis]], [[Eisenmenger syndrome]], [[endomyocardial fibrosis]], [[familial atrial fibrillation]], [[hypertensive heart disease]], [[hypertrophic cardiomyopathy]], [[ischemic heart disease]], [[Lutembacher syndrome]], [[mitral regurgitation]], [[mitral stenosis]], [[myocardial infarction]], [[myocarditis]], [[atrioventricular block|partial atrioventricular block]], [[pericarditis]], [[peripartum cardiomyopathy]], [[pulmonary embolism]], [[pulmonary hypertension]], [[short QT syndrome]], [[sick sinus syndrome]], [[sinoatrial block]], [[systemic hypertension]], [[tricuspid regurgitation]], [[tricuspid stenosis]], [[unstable angina]], [[uremic pericarditis]], [[valvular heart disease]], [[Wolff-Parkinson-White syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Chemical / | | '''Chemical/Poisoning''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| No underlying causes | ||
|- | |||
|-bgcolor="LightSteelBlue" | |||
| '''Dental''' | |||
|bgcolor="Beige"| No underlying causes | |||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 34: | Line 54: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Drug Side Effect''' | | '''Drug Side Effect''' | ||
|bgcolor="Beige"| [[ | |bgcolor="Beige"| [[Amphetamine]], [[caspofungin acetate]], [[conivaptan]], [[cyclophosphamide]], [[ciclosporin|cyclosporine toxicity]], [[etravirine]], [[febuxostat]], [[felbamate]], [[granisetron]], [[guanidine]], [[ibrutinib]], [[idarubicin hydrochloride]], [[ioxilan]], [[interleukin 2]], [[lacosamide]], [[metipranolol]], [[niacin]], [[oprelvekin]], [[pergolide]], [[porfimer sodium]], [[pramipexole]], [[ropinirole]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 42: | Line 62: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Endocrine''' | | '''Endocrine''' | ||
|bgcolor="Beige"| [[ | |bgcolor="Beige"| [[Diabetes]], [[Graves disease]], [[hyperthyroidism]], [[hypothyroidism]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Environmental''' | | '''Environmental''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| No underlying causes | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Gastroenterologic''' | | '''Gastroenterologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| No underlying causes | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Genetic''' | | '''Genetic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Familial atrial fibrillation]], [[hemochromatosis]], [[McLeod syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Hematologic''' | | '''Hematologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Hemochromatosis]], [[McLeod syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Iatrogenic''' | | '''Iatrogenic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| No underlying causes | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Infectious Disease''' | | '''Infectious Disease''' | ||
|bgcolor="Beige"| [[ | |bgcolor="Beige"| [[Viral infections]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Musculoskeletal / | | '''Musculoskeletal/Orthopedic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| No underlying causes | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Neurologic''' | | '''Neurologic''' | ||
|bgcolor="Beige"| [[Stroke]], [[ | |bgcolor="Beige"| [[Stroke]], [[subarachnoid hemorrhage]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Nutritional / Metabolic''' | | '''Nutritional/Metabolic''' | ||
|bgcolor="Beige"| [[ | |bgcolor="Beige"| [[Electrolyte disturbance]], [[ethanol]], [[hemochromatosis]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 86: | Line 106: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Oncologic''' | | '''Oncologic''' | ||
|bgcolor="Beige"| [[Atrial myxoma]], [[ | |bgcolor="Beige"| [[Atrial myxoma]], [[bronchogenic carcinoma]], [[cardiac tumors]], [[lung cancer]], [[pheochromocytoma]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| ''' | | '''Ophthalmologic''' | ||
|bgcolor="Beige"| No underlying causes | |bgcolor="Beige"| No underlying causes | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Overdose / Toxicity''' | | '''Overdose/Toxicity''' | ||
|bgcolor="Beige"| [[Alcohol]], [[ | |bgcolor="Beige"| [[Alcohol]], [[cocaine]], [[ciclosporin|cyclosporine toxicity]], [[methamphetamines]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 102: | Line 122: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Pulmonary''' | | '''Pulmonary''' | ||
|bgcolor="Beige"| [[Bronchogenic carcinoma]], [[ | |bgcolor="Beige"| [[Bronchogenic carcinoma]], [[chronic obstructive pulmonary disease]], [[hypoxia]], [[lung cancer]], [[obstructive sleep apnea]], [[pneumonia]], [[pulmonary embolism]], [[pulmonary hypertension]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Renal / Electrolyte''' | | '''Renal/Electrolyte''' | ||
|bgcolor="Beige"| [[ | |bgcolor="Beige"| [[Channelopaties ]], [[chronic kidney disease]], [[renal insufficiency]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| ''' | | '''Rheumatology/Immunology/Allergy''' | ||
|bgcolor="Beige"| [[Collagen vascular disease]], [[ | |bgcolor="Beige"| [[Collagen vascular disease]], [[rheumatic fever]], [[rheumatic heart disease]], [[sarcoidosis]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 118: | Line 138: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Trauma''' | | '''Trauma''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| No underlying causes | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 126: | Line 146: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Miscellaneous''' | | '''Miscellaneous''' | ||
|bgcolor="Beige"| [[ | |bgcolor="Beige"| [[Breath spray]], [[caffeine]], [[dehydration]], [[ethanol]], [[fatigue]], [[hypothermia]], [[psychological stress]], [[surgery]] | ||
|- | |- | ||
|} | |} | ||
===Causes in Alphabetical Order=== | ===Causes in Alphabetical Order=== | ||
{{columns-list| | |||
*[[Alcohol]] | *[[Alcohol]] | ||
*[[Alcoholic cardiomyopathy]] | |||
*[[Alcohol withdrawal]] | *[[Alcohol withdrawal]] | ||
*[[Amphetamine]] | |||
*[[atrial infarction|Atrial ischemia]] | *[[atrial infarction|Atrial ischemia]] | ||
*[[Atrial myxoma]] | *[[Atrial myxoma]] | ||
*[[Atrial septal defect]] | *[[Atrial septal defect]]<ref name="Tikoff-1968">{{Cite journal | last1 = Tikoff | first1 = G. | last2 = Schmidt | first2 = AM. | last3 = Hecht | first3 = HH. | title = Atrial fibrillation in atrial septal defect. | journal = Arch Intern Med | volume = 121 | issue = 5 | pages = 402-5 | month = May | year = 1968 | doi = | PMID = 5645716 }}</ref> | ||
*[[Breath spray]]<ref name="pmid2914028">{{cite journal| author=Ridker PM, Gibson CM, Lopez R| title=Atrial fibrillation induced by breath spray. | journal=N Engl J Med | year= 1989 | volume= 320 | issue= 2 | pages= 124 | pmid=2914028 | doi= | pmc= | url= }} </ref> | |||
*[[Bronchogenic carcinoma]] | *[[Bronchogenic carcinoma]] | ||
*[[Caffeine]] | *[[Caffeine]] | ||
*[[Cardiac surgery]] | |||
*[[Cardiac tumors]] | *[[Cardiac tumors]] | ||
*[[Cardiomyopathy]] | *[[Cardiomyopathy]] | ||
*[[Caspofungin acetate]] | |||
*[[Channelopaties]] | *[[Channelopaties]] | ||
*[[Chronic kidney disease]] | *[[Chronic kidney disease]] | ||
*[[Chronic obstructive pulmonary disease]] | *[[Chronic obstructive pulmonary disease]]<ref name="Buch-2003">{{Cite journal | last1 = Buch | first1 = P. | last2 = Friberg | first2 = J. | last3 = Scharling | first3 = H. | last4 = Lange | first4 = P. | last5 = Prescott | first5 = E. | title = Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study. | journal = Eur Respir J | volume = 21 | issue = 6 | pages = 1012-6 | month = Jun | year = 2003 | doi = | PMID = 12797497 }}</ref> | ||
*[[Cocaine]] | *[[Cocaine]] | ||
*[[Collagen vascular disease]] | *[[Collagen vascular disease]] | ||
*[[Conduction disorders]] | |||
*[[Congenital heart disease]] | *[[Congenital heart disease]] | ||
*[[Congestive heart failure]] | *[[Congestive heart failure]] | ||
Line 153: | Line 178: | ||
*[[Coronary artery bypass graft surgery]] | *[[Coronary artery bypass graft surgery]] | ||
*[[Coronary artery disease]] | *[[Coronary artery disease]] | ||
*[[Cyclophosphamide]] | |||
*[[ciclosporin|Cyclosporine toxicity]] | |||
*[[Dehydration]] | *[[Dehydration]] | ||
*[[Diabetes]] | *[[Diabetes]]<ref name="Benjamin-1994">{{Cite journal | last1 = Benjamin | first1 = EJ. | last2 = Levy | first2 = D. | last3 = Vaziri | first3 = SM. | last4 = D'Agostino | first4 = RB. | last5 = Belanger | first5 = AJ. | last6 = Wolf | first6 = PA. | title = Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. | journal = JAMA | volume = 271 | issue = 11 | pages = 840-4 | month = Mar | year = 1994 | doi = | PMID = 8114238 }}</ref> | ||
*[[Dilated cardiomyopathy]] | *[[Dilated cardiomyopathy]] | ||
*[[Electrolyte disturbance]] | *[[Electrolyte disturbance]] | ||
*[[Eisenmenger syndrome]] | |||
*[[Endocarditis]] | *[[Endocarditis]] | ||
*[[Endomyocardial fibrosis]] | |||
*[[Ethanol]] | |||
*[[Etravirine]] | |||
*[[Familial atrial fibrillation ]] | *[[Familial atrial fibrillation ]] | ||
*[[Fatigue]] | *[[Fatigue]] | ||
*[[ | *[[Febuxostat]] | ||
*[[Felbamate]] | |||
*[[Granisetron]] | |||
*[[Graves disease]] | |||
*[[Guanidine]] | |||
*[[Hemochromatosis]] | *[[Hemochromatosis]] | ||
*[[Hypertensive heart disease]]<ref name="Krahn-1995">{{Cite journal | last1 = Krahn | first1 = AD. | last2 = Manfreda | first2 = J. | last3 = Tate | first3 = RB. | last4 = Mathewson | first4 = FA. | last5 = Cuddy | first5 = TE. | title = The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. | journal = Am J Med | volume = 98 | issue = 5 | pages = 476-84 | month = May | year = 1995 | doi = 10.1016/S0002-9343(99)80348-9 | PMID = 7733127 }}</ref><ref name="Kannel-1982">{{Cite journal | last1 = Kannel | first1 = WB. | last2 = Abbott | first2 = RD. | last3 = Savage | first3 = DD. | last4 = McNamara | first4 = PM. | title = Epidemiologic features of chronic atrial fibrillation: the Framingham study. | journal = N Engl J Med | volume = 306 | issue = 17 | pages = 1018-22 | month = Apr | year = 1982 | doi = 10.1056/NEJM198204293061703 | PMID = 7062992 }}</ref> | |||
*[[Hyperthyroidism]] | *[[Hyperthyroidism]] | ||
*[[Hypertrophic cardiomyopathy]] | *[[Hypertrophic cardiomyopathy]]<ref name="Robinson-1990">{{Cite journal | last1 = Robinson | first1 = K. | last2 = Frenneaux | first2 = MP. | last3 = Stockins | first3 = B. | last4 = Karatasakis | first4 = G. | last5 = Poloniecki | first5 = JD. | last6 = McKenna | first6 = WJ. | title = Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study. | journal = J Am Coll Cardiol | volume = 15 | issue = 6 | pages = 1279-85 | month = May | year = 1990 | doi = | PMID = 2329232 }}</ref><ref name="Cecchi-1995">{{Cite journal | last1 = Cecchi | first1 = F. | last2 = Olivotto | first2 = I. | last3 = Montereggi | first3 = A. | last4 = Santoro | first4 = G. | last5 = Dolara | first5 = A. | last6 = Maron | first6 = BJ. | title = Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. | journal = J Am Coll Cardiol | volume = 26 | issue = 6 | pages = 1529-36 | month = Nov | year = 1995 | doi = 10.1016/0735-1097(95)00353-3 | PMID = 7594081 }}</ref> | ||
*[[Hypothermia]] | *[[Hypothermia]] | ||
*[[Hypothyroidism]] | *[[Hypothyroidism]] | ||
*[[Hypoxia]] | *[[Hypoxia]] | ||
*[[ | *[[Ibrutinib]] | ||
*[[Idarubicin hydrochloride]] | |||
*[[Interleukin 2]] | |||
*[[Ioxilan]] | |||
*[[Ischemic heart disease]] | |||
*[[Lacosamide]] | |||
*[[Left ventricular hypertrophy]] | *[[Left ventricular hypertrophy]] | ||
*[[Lung cancer]] | *[[Lung cancer]] | ||
*[[Lutembacher syndrome]] | *[[Lutembacher syndrome]] | ||
*[[ | *[[McLeod syndrome]] | ||
*[[Methamphetamines]] | *[[Methamphetamines]] | ||
*[[Mitral regurgitation]] | *[[Metipranolol]] | ||
*[[Mitral regurgitation]]<ref name="Grigioni-2002">{{Cite journal | last1 = Grigioni | first1 = F. | last2 = Avierinos | first2 = JF. | last3 = Ling | first3 = LH. | last4 = Scott | first4 = CG. | last5 = Bailey | first5 = KR. | last6 = Tajik | first6 = AJ. | last7 = Frye | first7 = RL. | last8 = Enriquez-Sarano | first8 = M. | title = Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome. | journal = J Am Coll Cardiol | volume = 40 | issue = 1 | pages = 84-92 | month = Jul | year = 2002 | doi = | PMID = 12103260 }}</ref> | |||
*[[Mitral stenosis]] | *[[Mitral stenosis]] | ||
*[[Myocardial infarction]] | *[[Myocardial infarction]]<ref name="Zimetbaum-2000">{{Cite journal | last1 = Zimetbaum | first1 = PJ. | last2 = Josephson | first2 = ME. | last3 = McDonald | first3 = MJ. | last4 = McClennen | first4 = S. | last5 = Korley | first5 = V. | last6 = Ho | first6 = KK. | last7 = Papageorgiou | first7 = P. | last8 = Cohen | first8 = DJ. | title = Incidence and predictors of myocardial infarction among patients with atrial fibrillation. | journal = J Am Coll Cardiol | volume = 36 | issue = 4 | pages = 1223- | ||
7 | month = Oct | year = 2000 | doi = | PMID = 11028474 }}</ref> | |||
*[[Myocarditis]] | *[[Myocarditis]] | ||
*[[Niacin]] | |||
*[[Obstructive sleep apnea]] | *[[Obstructive sleep apnea]] | ||
*[[Oprelvekin]] | |||
*[[atrioventricular block|Partial atrioventricular block]] | |||
*[[Pergolide]] | |||
*[[Pericarditis]] | *[[Pericarditis]] | ||
*[[Peripartum cardiomyopathy]] | *[[Peripartum cardiomyopathy]]<ref name="WALSH-1965">{{Cite journal | last1 = WALSH | first1 = JJ. | last2 = BURCH | first2 = GE. | last3 = BLACK | first3 = WC. | last4 = FERRANS | first4 = VJ. | last5 = HIBBS | first5 = RG. | title = IDIOPATHIC MYOCARDIOPATHY OF THE PUERPERIUM (POSTPARTAL HEART DISEASE). | journal = Circulation | volume = 32 | issue = | pages = 19-31 | month = Jul | year = 1965 | doi = | PMID = 14314486 }}</ref> | ||
*[[Pheochromocytoma]] | *[[Pheochromocytoma]] | ||
*[[Pneumonia]] | *[[Pneumonia]] | ||
*[[Porfimer sodium]] | *[[Porfimer sodium]] | ||
*[[Pramipexole]] | |||
*[[Psychological stress]] | *[[Psychological stress]] | ||
*[[Pulmonary embolism]] | *[[Pulmonary embolism]]<ref name="Goldhaber-1999">{{Cite journal | last1 = Goldhaber | first1 = SZ. | last2 = Visani | first2 = L. | last3 = De Rosa | first3 = M. | title = Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) | journal = Lancet | volume = 353 | issue = 9162 | pages = 1386-9 | month = Apr | year = 1999 | doi = | PMID = 10227218 }}</ref> | ||
*[[Pulmonary hypertension]] | *[[Pulmonary hypertension]] | ||
*[[Renal insufficiency]] | *[[Renal insufficiency]] | ||
*[[Rheumatic heart disease]] | *[[Rheumatic fever]] | ||
*[[Rheumatic heart disease]]<ref name="Grigioni-2002">{{Cite journal | last1 = Grigioni | first1 = F. | last2 = Avierinos | first2 = JF. | last3 = Ling | first3 = LH. | last4 = Scott | first4 = CG. | last5 = Bailey | first5 = KR. | last6 = Tajik | first6 = AJ. | last7 = Frye | first7 = RL. | last8 = Enriquez-Sarano | first8 = M. | title = Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome. | journal = J Am Coll Cardiol | volume = 40 | issue = 1 | pages = 84-92 | month = Jul | year = 2002 | doi = | PMID = 12103260 }}</ref> | |||
*[[Ropinirole]] | |||
*[[Sarcoidosis]] | *[[Sarcoidosis]] | ||
*[[Short QT syndrome]] | |||
*[[Sick sinus syndrome]] | |||
*[[Sinoatrial block]] | |||
*[[Stroke]] | *[[Stroke]] | ||
*[[Subarachnoid hemorrhage]] | *[[Subarachnoid hemorrhage]] | ||
*[[Surgery]] | *[[Surgery]] | ||
*[[Systemic hypertension]] | |||
*[[Tricuspid regurgitation]] | *[[Tricuspid regurgitation]] | ||
*[[Tricuspid stenosis]] | *[[Tricuspid stenosis]] | ||
Line 198: | Line 252: | ||
*[[Valvular heart disease]] | *[[Valvular heart disease]] | ||
*[[Viral infections]] | *[[Viral infections]] | ||
*[[Wolff-Parkinson-White syndrome]] | |||
}} | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[CME Category::Cardiology]] | |||
[[Category:Crowdiagnosis]] | |||
[[Category:Cardiology]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Up-To-Date cardiology]] | |||
[[Category:Arrhythmia]] | |||
[[Category:Electrophysiology]] | [[Category:Electrophysiology]] | ||
[[Category: | [[Category:Disease]] | ||
Latest revision as of 20:13, 29 August 2021
Resident Survival Guide |
Atrial Fibrillation Microchapters | |
Special Groups | |
---|---|
Diagnosis | |
Treatment | |
Cardioversion | |
Anticoagulation | |
Surgery | |
Case Studies | |
Atrial fibrillation causes On the Web | |
Risk calculators and risk factors for Atrial fibrillation causes | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hilda Mahmoudi M.D., M.P.H.[2] Ogheneochuko Ajari, MB.BS, MS [3]
Overview
The most common cause of atrial fibrillation is atrial dilation associated with hypertension. Atrial fibrillation can be caused by several organic cardiac diseases, but it has also been reported to have a familial etiology in some patients. Approximately 1/3 of patients have familial atrial fibrillation which is due to an underlying genetic disorder. In developed countries, hypertensive heart disease and coronary heart disease are the two most common causes of atrial fibrillation. However, rheumatic heart disease is associated with a higher incidence of atrial fibrillation in developing countries. Life threatening conditions such as acute coronary syndromes, electrolyte imbalance, dehydration, hypoxia, pulmonary embolism, myocarditis and pericarditis should be identified and promptly treated. Other general causes such as the advancing age of the population, the hemodynamic stress of heart failure and valvular heart disease, myocardial ischemia, a variety of inflammatory disorders, pulmonary diseases, alcohol, drug abuse, and endocrine disorders.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. The following are some of the well known life threatening causes of atrial fibrillation:[1][2][3]
- Congestive heart failure
- Dehydration
- Electrolyte disturbance
- Hypothermia
- Hypoxia
- Myocardial infarction
- Myocarditis
- Pericarditis
- Pulmonary embolism
- Uremic pericarditis
Common Causes
The following are the common causes of atrial fibrillation:[4][5][6]
Causes by Organ System
Causes in Alphabetical Order
- Alcohol
- Alcoholic cardiomyopathy
- Alcohol withdrawal
- Amphetamine
- Atrial ischemia
- Atrial myxoma
- Atrial septal defect[7]
- Breath spray[8]
- Bronchogenic carcinoma
- Caffeine
- Cardiac surgery
- Cardiac tumors
- Cardiomyopathy
- Caspofungin acetate
- Channelopaties
- Chronic kidney disease
- Chronic obstructive pulmonary disease[9]
- Cocaine
- Collagen vascular disease
- Conduction disorders
- Congenital heart disease
- Congestive heart failure
- Conivaptan
- Constrictive pericarditis
- Coronary artery bypass graft surgery
- Coronary artery disease
- Cyclophosphamide
- Cyclosporine toxicity
- Dehydration
- Diabetes[10]
- Dilated cardiomyopathy
- Electrolyte disturbance
- Eisenmenger syndrome
- Endocarditis
- Endomyocardial fibrosis
- Ethanol
- Etravirine
- Familial atrial fibrillation
- Fatigue
- Febuxostat
- Felbamate
- Granisetron
- Graves disease
- Guanidine
- Hemochromatosis
- Hypertensive heart disease[4][5]
- Hyperthyroidism
- Hypertrophic cardiomyopathy[11][12]
- Hypothermia
- Hypothyroidism
- Hypoxia
- Ibrutinib
- Idarubicin hydrochloride
- Interleukin 2
- Ioxilan
- Ischemic heart disease
- Lacosamide
- Left ventricular hypertrophy
- Lung cancer
- Lutembacher syndrome
- McLeod syndrome
- Methamphetamines
- Metipranolol
- Mitral regurgitation[6]
- Mitral stenosis
- Myocardial infarction[2]
- Myocarditis
- Niacin
- Obstructive sleep apnea
- Oprelvekin
- Partial atrioventricular block
- Pergolide
- Pericarditis
- Peripartum cardiomyopathy[13]
- Pheochromocytoma
- Pneumonia
- Porfimer sodium
- Pramipexole
- Psychological stress
- Pulmonary embolism[3]
- Pulmonary hypertension
- Renal insufficiency
- Rheumatic fever
- Rheumatic heart disease[6]
- Ropinirole
- Sarcoidosis
- Short QT syndrome
- Sick sinus syndrome
- Sinoatrial block
- Stroke
- Subarachnoid hemorrhage
- Surgery
- Systemic hypertension
- Tricuspid regurgitation
- Tricuspid stenosis
- Unstable angina
- Uremic pericarditis
- Valvular heart disease
- Viral infections
- Wolff-Parkinson-White syndrome
References
- ↑ Fox, CS.; Parise, H.; D'Agostino, RB.; Lloyd-Jones, DM.; Vasan, RS.; Wang, TJ.; Levy, D.; Wolf, PA.; Benjamin, EJ. (2004). "Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring". JAMA. 291 (23): 2851–5. doi:10.1001/jama.291.23.2851. PMID 15199036. Unknown parameter
|month=
ignored (help) - ↑ 2.0 2.1 Zimetbaum, PJ.; Josephson, ME.; McDonald, MJ.; McClennen, S.; Korley, V.; Ho, KK.; Papageorgiou, P.; Cohen, DJ. (2000). "Incidence and predictors of myocardial infarction among patients with atrial fibrillation". J Am Coll Cardiol. 36 (4): 1223–7. PMID 11028474. Unknown parameter
|month=
ignored (help) - ↑ 3.0 3.1 Goldhaber, SZ.; Visani, L.; De Rosa, M. (1999). "Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)". Lancet. 353 (9162): 1386–9. PMID 10227218. Unknown parameter
|month=
ignored (help) - ↑ 4.0 4.1 Krahn, AD.; Manfreda, J.; Tate, RB.; Mathewson, FA.; Cuddy, TE. (1995). "The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study". Am J Med. 98 (5): 476–84. doi:10.1016/S0002-9343(99)80348-9. PMID 7733127. Unknown parameter
|month=
ignored (help) - ↑ 5.0 5.1 Kannel, WB.; Abbott, RD.; Savage, DD.; McNamara, PM. (1982). "Epidemiologic features of chronic atrial fibrillation: the Framingham study". N Engl J Med. 306 (17): 1018–22. doi:10.1056/NEJM198204293061703. PMID 7062992. Unknown parameter
|month=
ignored (help) - ↑ 6.0 6.1 6.2 Grigioni, F.; Avierinos, JF.; Ling, LH.; Scott, CG.; Bailey, KR.; Tajik, AJ.; Frye, RL.; Enriquez-Sarano, M. (2002). "Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome". J Am Coll Cardiol. 40 (1): 84–92. PMID 12103260. Unknown parameter
|month=
ignored (help) - ↑ Tikoff, G.; Schmidt, AM.; Hecht, HH. (1968). "Atrial fibrillation in atrial septal defect". Arch Intern Med. 121 (5): 402–5. PMID 5645716. Unknown parameter
|month=
ignored (help) - ↑ Ridker PM, Gibson CM, Lopez R (1989). "Atrial fibrillation induced by breath spray". N Engl J Med. 320 (2): 124. PMID 2914028.
- ↑ Buch, P.; Friberg, J.; Scharling, H.; Lange, P.; Prescott, E. (2003). "Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study". Eur Respir J. 21 (6): 1012–6. PMID 12797497. Unknown parameter
|month=
ignored (help) - ↑ Benjamin, EJ.; Levy, D.; Vaziri, SM.; D'Agostino, RB.; Belanger, AJ.; Wolf, PA. (1994). "Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study". JAMA. 271 (11): 840–4. PMID 8114238. Unknown parameter
|month=
ignored (help) - ↑ Robinson, K.; Frenneaux, MP.; Stockins, B.; Karatasakis, G.; Poloniecki, JD.; McKenna, WJ. (1990). "Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study". J Am Coll Cardiol. 15 (6): 1279–85. PMID 2329232. Unknown parameter
|month=
ignored (help) - ↑ Cecchi, F.; Olivotto, I.; Montereggi, A.; Santoro, G.; Dolara, A.; Maron, BJ. (1995). "Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population". J Am Coll Cardiol. 26 (6): 1529–36. doi:10.1016/0735-1097(95)00353-3. PMID 7594081. Unknown parameter
|month=
ignored (help) - ↑ WALSH, JJ.; BURCH, GE.; BLACK, WC.; FERRANS, VJ.; HIBBS, RG. (1965). "IDIOPATHIC MYOCARDIOPATHY OF THE PUERPERIUM (POSTPARTAL HEART DISEASE)". Circulation. 32: 19–31. PMID 14314486. Unknown parameter
|month=
ignored (help)